China Feihe Limited Announces Discloseable Financial Product Subscription – Potential Share Price Implications
Key Highlights
- China Feihe Limited (“Feihe” or the “Company”) has announced a new subscription of a wealth management financial product from CITIC Bank by Heilongjiang Feihe Dairy Co., Limited (“Feihe HLJ”), a wholly-owned subsidiary.
- The subscription involves RMB200 million of idle funds invested in CITIC Bank’s “Xinyin Wealth Management Allwin Xiangzhiying Fixed Income Enhanced Profit Closed-ended Wealth Management Product No. 30”.
- The product offers a non-principal guaranteed floating return with an expected annual yield of 2.40%, maturing on 9 June 2027.
- Total outstanding principal for all CITIC Bank financial products held by the Group now stands at RMB2.2 billion.
Detailed Analysis for Investors
China Feihe Limited has taken a strategic step to enhance its treasury management by deploying RMB200 million of idle cash into a fixed income wealth management product from CITIC Bank. The management has negotiated the terms at arm’s length, taking into account the Group’s surplus cash position and the expected returns from this product.
The invested product is non-principal guaranteed, meaning there is some risk to capital, but it promises a relatively attractive floating return rate of 2.40% compared to regular savings or time deposits offered by commercial banks in China. The product is closed-ended with a maturity date set for 9 June 2027. The Group’s total exposure to CITIC Bank financial products now amounts to RMB2.2 billion, indicating a significant allocation of corporate funds into wealth management and structured deposit products.
This move is aligned with Feihe’s core objectives: ensuring capital safety, liquidity, and supporting operational and dividend needs. The Directors assure that internal controls are in place to ensure this investment will not impact the Group’s working capital or daily operations.
Shareholder Considerations & Price Sensitive Information
- Strategic Use of Idle Funds: The Company’s decision to invest idle funds in a higher yielding product could enhance overall capital efficiency, supporting profitability and possibly future dividends.
- Risk Profile: The product is non-principal guaranteed. Although the risk is described as low, there remains exposure to floating returns and potential capital loss.
- Regulatory Disclosure: The aggregate value of CITIC Bank products now exceeds 5% but is less than 25% of the Company’s total assets, triggering a discloseable transaction under Hong Kong Listing Rules. No shareholder approval is required, but notification and announcement requirements apply.
- Impact on Share Price: The significant allocation of funds into structured products, and the potential for enhanced returns, may be viewed positively by investors seeking capital efficiency. However, the non-guaranteed nature of the investment introduces risk, which could affect investor sentiment and share value.
Corporate Profiles
- China Feihe Limited: Incorporated in the Cayman Islands, listed on the Main Board of the Stock Exchange, focused on dairy products, raw milk, and nutritional supplements.
- CITIC Bank: A leading PRC joint stock bank, listed on both Hong Kong and Shanghai stock exchanges, offering a broad range of financial products.
Board Statement
The Board considers the terms of the subscription fair and reasonable, conducted on normal commercial terms, and in the interests of both the Company and its shareholders.
All relevant parties, including CITIC Bank and its ultimate owners, are confirmed as independent third parties to the Company.
Directors and Governance
- Executive Directors: Mr. Leng Youbin, Mr. Liu Hua, Mr. Cai Fangliang, Ms. Judy Fong-Yee Tu
- Non-executive Directors: Mr. Gao Yu, Mr. Cheung Kwok Wah, Mr. Maher EL-OMARI (Mac)
- Independent Non-executive Directors: Ms. Liu Jinping, Mr. Song Jianwu, Mr. Fan Yonghong, Mr. Jacques Maurice Laforge
Important Dates
- Subscription Date: 12 June 2026
- Maturity Date: 9 June 2027
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult professional advisors before making investment decisions. The information is based on public disclosures and may be subject to change.
中國飛鶴有限公司公佈重大金融產品認購 —— 股價可能受影響的詳情
重點摘要
- 中國飛鶴有限公司（「飛鶴」或「公司」）公佈其全資子公司黑龍江飛鶴乳業有限公司（「飛鶴黑龍江」）認購中信銀行財富管理產品。
- 此次認購涉及將2億元人民幣閒置資金投資於「信銀財富管理盈享祥智盈固定收益增利封閉式理財產品30號」。
- 該產品為非保本浮動收益，預期年化收益2.40%，到期日為2027年6月9日。
- 集團於中信銀行認購的所有財務產品累計本金現已達到22億元人民幣。
投資者詳細分析
中國飛鶴有限公司通過將2億元閒置資金投入中信銀行的固定收益財富管理產品，增強資金運用效率。管理層經商業談判，考慮集團現有閒置資金及投資回報，確定認購條款。
該產品非保本，雖風險較低，但本金有損失可能，且收益為浮動。封閉式產品，2027年6月9日到期。集團現於中信銀行的財務產品投資總額達22億元人民幣，顯示公司資金管理策略偏向理財及結構性存款。
此舉符合飛鶴核心目標：保障資本安全、流動性及滿足日常運營和分紅需求。董事會表示已設立內控措施，確保該投資不會影響集團運營資金及日常業務。
股東須知及可能影響股價的事項
- 閒置資金策略性運用：資金投向高收益產品，有望提升資本效率及盈利，或支持未來分紅。
- 風險提示：產品非保本，雖風險低但存在本金損失可能，收益浮動。
- 監管披露：中信銀行理財產品總額佔公司總資產超過5%但低於25%，屬披露交易，無需股東批准但需公告。
- 股價影響：大額資金投向結構性理財產品及潛在高回報，或被投資者視為資本效率提升，惟風險增加亦可能影響市場情緒及股價。
公司簡介
- 中國飛鶴有限公司：在開曼群島註冊，港交所主板上市，業務涵蓋乳製品、原料奶及營養補充劑。
- 中信銀行：內地股份制銀行，港股及上交所上市，提供全面金融產品。
董事會聲明
董事會認為本次認購條款公平合理，屬正常商業條款，符合公司及股東利益。
所有相關方，包括中信銀行及其最終實益擁有人，均為公司獨立第三方。
董事及治理
- 執行董事：冷友斌、劉華、蔡方良、杜方怡
- 非執行董事：高宇、張國華、Maher EL-OMARI（Mac）
- 獨立非執行董事：劉錦平、宋建武、范永紅、Jacques Maurice Laforge
重要日期
- 認購日期：2026年6月12日
- 到期日期：2027年6月9日
免責聲明
本文僅供資訊參考，不構成投資建議。投資者應自行審慎評估，並諮詢專業顧問。所有資料均以公開披露為依據，可能隨時變更。
